NIH-funded research NIH-funded research

Comparing natural COVID-19 infection and vaccine-induced immunity in pregnant women and their infants

Official title: SARS-CoV-2 in Pregnancy: Comparison of Natural Infection and Hybrid Immunity in Mother-Infant Pairs

Funded at University of California Los Angeles · NIH-10881968 · Data updated 2026-11-12

This study is looking at how getting COVID-19 and being vaccinated during pregnancy affects both moms and their babies, especially how different types of immunity can help protect newborns.

More Pregnancy research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of California Los Angeles
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startJuly 5, 2023
Project endJune 30, 2028
Funding year2024
Award (this year)$203,580
NIH project number5K23AI177952-02
Project IDNIH-10881968 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation include pregnant women who have experienced either natural SARS-CoV-2 infection or vaccination against COVID-19.

Less likely to help

Patients who are not pregnant or those who have not been exposed to SARS-CoV-2 or vaccinated may not benefit from this research.

What this research studies

This research investigates the effects of SARS-CoV-2 infection and vaccination during pregnancy on both mothers and their infants. It aims to understand how hybrid immunity, which combines natural infection and vaccination, influences immune responses in pregnant women compared to those who only experience natural infection. By studying mother-infant pairs, the research will explore the long-term immunological impacts of these different types of immunity, particularly focusing on the transfer of protective antibodies to newborns. This study leverages data from an existing cohort of mothers and infants affected by COVID-19 during pregnancy.

Why it matters

Potential benefit: If successful, this research could enhance understanding of how to protect pregnant women and their infants from severe COVID-19 outcomes.

How similar studies have gone: Previous research has shown promising results in understanding immunity in pregnant populations, but this specific comparison of hybrid immunity is relatively novel.

Where this research is happening

  • University of California Los Angeles
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Cambou, Mary Catherine — University of California Los Angeles
  • Study coordinator: Cambou, Mary Catherine

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.